AirSculpt Technologies, Inc. Common Stock (AIRS) is a publicly traded Healthcare sector company. As of May 21, 2026, AIRS trades at $4.98 with a market cap of $335.80M and a P/E ratio of -31.28. AIRS moved +4.63% today. Year to date, AIRS is +155.78%; over the trailing twelve months it is +33.77%. Its 52-week range spans $1.51 to $12.00. Analyst consensus is neutral with an average price target of $4.50. Rallies surfaces AIRS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AirSculpt Q4 Revenue Falls 14.6% to $33.4M, 2026 Outlook $151–$157M: AirSculpt’s Q4 2025 revenue fell 14.6% to $33.4 million on 2,604 procedures, while net loss narrowed to $1.3 million and adjusted EBITDA swung to a $0.1 million loss. Full year 2025 revenue declined 15.8% to $151.8 million with adjusted EBITDA of $12.5 million; 2026 revenue guidance is $151–$157 million with $15–$17 million EBITDA.
| Metric | Value |
|---|---|
| Price | $4.98 |
| Market Cap | $335.80M |
| P/E Ratio | -31.28 |
| EPS | $-0.16 |
| Dividend Yield | 0.41% |
| 52-Week High | $12.00 |
| 52-Week Low | $1.51 |
| Volume | 238 |
| Avg Volume | 0 |
| Revenue (TTM) | $151.84M |
| Net Income | $-11.22M |
| Gross Margin | 0.00% |
2 analysts cover AIRS: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $4.50.